Use of Intrathecal Hydromorphone in Elective Cesarean Deliveries

The purpose of this study is to determine if intrathecal hydromorphone will relieve pain as
well as intrathecal morphine after cesarean delivery, with fewer side effects.

Eligibility Criteria

Inclusion Criteria:

- Scheduled for elective Cesarean sections under spinal anesthesia or combined spinal
anesthesia

- ASA status of I-III

- BMI < 40

- Able to understand and sign informed consent
 

Exclusion Criteria:

- Severe pre-eclampsia

- Conversion to general anesthetic

- History of chronic opioid use

- Allergy to morphine, or hydromorphone

- Hyperemesis gravidarum

- Emergency case

- Patients who have an infection at the intended site of spinal insertion

Principal Investigator

Grace Shih, MD

Study Contact

Stephanie Thomas-Dodson, RN, BSN, sthomas-dodson@kumc.edu, (913) 588-0057

Estimated Completion Date

Friday, December 1, 2017

ClinicalTrials.gov #

NCT01866254
06/25/2015